Value proposition

First-in-human data to accelerate drug development

Genoskin uses donated human skin samples that are kept alive to generate first-in-human clinical data in order to help researchers, pharmaceutical, biotech and cosmetic companies de-risk drug & compound development.

Our live human skin models are immunocompetent and allow testing topical and systemic administrations as well as subcutaneous injections to characterize human skin reactions and immune response under multiple conditions.

Our expert team follows strict regulatory guidelines to comply with all applicable ethical and quality regulations.


Skin biology, Tissue culture, Tissue engineering, Cell culture, Skin explant, Ex vivo skin, Human skin, Histology, 3D skin imaging, Express shipment, Biological samples, alternatives to animal testing, biotechnology, human skin models, human skin response, Pharmacodynamics, Pharmacocinetics, Toxicology, Efficacy, Subcutaneous administration, Topical administration, and Drug Development Research